Zhang Dongfeng, Lv Shuzheng, Song Xiantao, Yuan Fei, Xu Feng, Zhang Min, Yan Shuai, Cao Xingmei
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Heart. 2015 Mar;101(6):455-62. doi: 10.1136/heartjnl-2014-306578. Epub 2015 Jan 30.
The purpose of this study was to investigate whether fractional flow reserve (FFR) should be performed for patients with coronary artery disease (CAD) to guide the percutaneous coronary intervention (PCI) strategy.
PCI is the most effective method to improve the outcomes of CAD. However, the proper usage of PCI has not been achieved in clinical practice.
A meta-analysis was performed on angiography-guided PCI and FFR-guided PCI strategies. Prospective and retrospective studies were included when research subjects were patients with CAD undergoing PCI. The primary endpoint was the rate of major adverse cardiac events (MACE) or major adverse cardiac and cerebrovascular events (MACCE). Secondary endpoints included death, myocardial infarction (MI), repeat revascularisation and death or MI.
Four prospective and three retrospective studies involving 49 517 patients were included. Absolute risks of MACE/MACCE, death, MI, revascularisation and death or MI for angiography-guided PCI and FFR-guided PCI were 34.8% vs 22.5%, 15.3% vs 7.6%, 8.1% vs 4.2%, 20.4% vs 14.8%, and 21.9% vs 11.8%, respectively. The meta-analysis demonstrated that FFR-guided PCI was associated with lower MACE/MACCE (OR: 1.71, 95% CI 1.31 to 2.23), death (OR: 1.64, 95% CI 1.37 to 1.96), MI (OR: 2.05, 95% CI 1.61 to 2.60), repeat revascularisation (OR: 1.25, 95% CI 1.09 to 1.44), and death or MI (OR: 1.84, 95% CI 1.58 to 2.15) than angiography-guided PCI strategy.
This meta-analysis supports current guidelines advising the FFR-guided PCI strategy for CAD. PCI should only be performed when haemodynamic significance is found.
本研究旨在探讨对于冠状动脉疾病(CAD)患者,是否应进行血流储备分数(FFR)检测以指导经皮冠状动脉介入治疗(PCI)策略。
PCI是改善CAD预后的最有效方法。然而,在临床实践中尚未实现PCI的合理应用。
对血管造影引导的PCI策略和FFR引导的PCI策略进行荟萃分析。当研究对象为接受PCI的CAD患者时,纳入前瞻性和回顾性研究。主要终点是主要不良心脏事件(MACE)或主要不良心脑血管事件(MACCE)的发生率。次要终点包括死亡、心肌梗死(MI)、再次血运重建以及死亡或MI。
纳入了四项前瞻性研究和三项回顾性研究,共49517例患者。血管造影引导的PCI和FFR引导的PCI的MACE/MACCE、死亡、MI、血运重建以及死亡或MI的绝对风险分别为34.8%对22.5%、15.3%对7.6%、8.1%对4.2%、20.4%对14.8%以及21.9%对11.8%。荟萃分析表明,与血管造影引导的PCI策略相比,FFR引导的PCI与更低的MACE/MACCE(比值比:1.71,95%置信区间1.31至2.23)、死亡(比值比:1.64,95%置信区间1.37至1.96)、MI(比值比:2.05,95%置信区间1.61至2.60)、再次血运重建(比值比:1.25,95%置信区间1.09至1.44)以及死亡或MI(比值比:1.84,95%置信区间1.58至2.15)相关。
这项荟萃分析支持当前指南建议的针对CAD的FFR引导的PCI策略。仅当发现血流动力学意义时才应进行PCI。